Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (4482)	8/15/2001 5:03:44 PM
From: Ian@SI	Read Replies (1) \| Respond to of 52153

Peter, I definitely agree that skepticism is the wisest policy; but for the life of me, I can't think of what a "neutral" source might be. Everyone seems to have their own agenda. I have no BPUR position, but do have a small HMSL one. I didn't particularly care for the bovine source; and I found it unusual that the company would do its phase III in an African country... While I haven't checked it out, I do believe that it is a US based company and would have expected it to at least have some of the clinical trial sites in the US; and would have consulted with the FDA prior to initiating a PHIII let alone completing one. As with most things, time will clear up any doubts one way or the other. RAGL, Ian